|
ASCO - Management of Immune-Related Adverse Events in Patients Treated with Immune Checkpoint Inhibitor Therapy (juin 2018)
|
|
ESMO - Management of toxicities from immunotherapy (juillet 2017)
|
|
NCCN - Management of Immunotherapy-Related Toxicities ***connexion requise*** (décembre 2019)
|
Groupe d'étude en oncologie du Québec